地特胰岛素对2型糖尿病患者人体成分的影响
2017-02-27朱珠罗兰卢林娜
朱珠 罗兰 卢林娜
【摘要】 目的:评价口服降糖药控制不佳的2型糖尿病患者加用地特胰岛素对人体成分的影响。方法:选取2010年2-9月大连市中心医院就诊的27例口服降糖药控制不佳的2型糖尿病患者(均符合1999年WHO的糖尿病诊断标准),在原有治疗方案的基础上加用地特胰岛素6~8 U/d起始治疗,治疗期为3个月,治疗前后分别应用Inbody 720人体成分分析仪进行人体成分分析,同时测定27例患者治疗前后身高、体重、糖化血红蛋白等,并比较治疗前后相关指标的变化。结果:治疗3个月后患者HbA1c较前明显下降,差异有统计学意义(t=5.116,P<0.001)。治疗3个月后体脂百分数较前下降,差异有统计学意义(t=2.161,P<0.05)。治疗3个月后体重、BMI、腰臀比、蛋白质、无机盐、脂肪量、肌肉量、内脏脂肪面积等与治疗前相比,差异均无统计学意义(P>0.05)。结论:对口服药控制不佳的2型糖尿病患者加用地特胰岛素治疗,在血糖明显下降的同时,体重呈下降趋势,其中肌肉量无明显变化,但体脂肪比例明显下降。
【关键词】 2型糖尿病; 地特胰岛素; 人体成分
【Abstract】 Objective:To evaluate the effect of once-daily Insulin Detemir on the body composition in poorly controlled type 2 diabetes patients treated with oral antidiabetic drugs.Method:A total of 27 cases type 2 diabetes patients with poor glycemic control by oral antidiabetic drugs were added to receive once-daily bedtime Insulin Detemir injection.The observation lasted for 3 months.The parameters of the body composition were measured before and after treatment by Inbody 720 body composition analyzer.The parameters included height weight and HbA1c also were measured before and after treatment.Result:After 3 months of treatment,HbA1c was significantly decreased than before treatment(t=5.116,P<0.001).After 3 months of treatment,the percentage of fat was significantly decreased than before treatment(t=2.161,P<0.05).Conclusion:Once-daily Insulin Detemir added to oral antidiabetic drugs in poorly controlled type 2 diabetes patients can improve glycemic control.At the same time weight on a downward trend which muscles no obvious changes,but fat ratio declined markedly.
【Key words】 Type 2 diabetes mellitus; Insulin Detemir; Body composition
First-authors address:Dalian Municipal Central Hospital Affiliated to Dalian Medical University,Dalian 116033,China
doi:10.3969/j.issn.1674-4985.2016.32.009
許多经典的大型研究,比如DCCT、UKPDS等研究表明,良好的血糖控制在延缓或者减少糖尿病患者微血管及大血管并发症的发生方面有重要的作用。近些年,无论是美国糖尿病学会、国际糖尿病联盟,还是我国糖尿病指南的推荐,均建议对口服降糖药疗效不佳的2型糖尿病患者,应尽早启用胰岛素治疗。其中增加基础胰岛素是目前2型糖尿病患者广泛选择的一种起始胰岛素治疗方案[1-3]。然而由于各种顾虑,包括担心胰岛素相关的低血糖和体重增加问题,很多患者及医生在即使口服药物治疗血糖不达标的情况下,也不愿起始胰岛素治疗。其中,本已处于超重情况的2型糖尿病患者尤其担心胰岛素治疗带来的体重增加问题。……
